Sign In
Buy HERO
$25.65
-0.633 (-2.41%)
At Close: Jun 03, 2026
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
04:01pm, Thursday, 14'th May 2026
SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark or the Company) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule
Forget Generic Gaming Plays: 3 ETFs Reveal the Real Digital Entertainment Divide
01:55pm, Friday, 24'th Apr 2026
Digital entertainment has grown into one of the largest discretionary categories for consumers, and it continues to draw more time and attention every year.
Video Gaming Industry's $22B AI Profit Boost: ETFs to Tap the Upside
01:46pm, Thursday, 23'rd Apr 2026
AI in the video gaming industry could cut development costs by 50%, unlocking $22B in profits, lifting ETF plays like ESPO and HERO.
ROYAL CARIBBEAN'S HERO OF THE SEAS INTRODUCES THE NEXT EVOLUTION OF FAMILY VACATION EXPERIENCES
09:03am, Monday, 30'th Mar 2026
Arriving August 2027 in Miami, the new Icon Class vacation levels up family time with more ways to splash, adventure, dine and more MIAMI, March 30, 2026 /PRNewswire/ -- Introducing the hero of family
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
04:05pm, Friday, 27'th Feb 2026
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics
A HERO RISES IN THE NEW TRAILER FOR EXODUS
09:00pm, Thursday, 11'th Dec 2025
RENTON, Wash. & AUSTIN, Texas--(BUSINESS WIRE)--Wizards of the Coast and Archetype Entertainment today debuted the new trailer for EXODUS™ at The Game Awards. The trailer provides fans with a more i
Flow Traders U.S. LLC Sells 21,186 Shares of Global X Video Games & Esports ETF $HERO
04:07am, Thursday, 11'th Dec 2025
Flow Traders U.S. LLC trimmed its position in Global X Video Games and Esports ETF (NASDAQ: HERO) by 53.4% in the second quarter, according to its most recent Form 13F filing with the Securities and E
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
04:05pm, Wednesday, 10'th Dec 2025
Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readout Clinical trial sites in Canada and the United Kingdom have received regulatory clearance to e
HERO: Gaming Industry Has A Favorable Momentum
05:50am, Monday, 08'th Dec 2025
HERO ETF offers investors an opportunity to benefit from companies in the video game industry. The prospects of the industry are improving thanks to the structural changes and the in-game monetization
SSCP-OWNED APPLEBEE'S IN TEXAS, CALIFORNIA AND VIRGINIA ENCOURAGE GUESTS TO 'BUY A HERO A BUD' IN ANTICIPATION OF VETERANS DAY
10:12am, Thursday, 09'th Oct 2025
Applebee's franchise partner expects to sell 10,000 Bud Light beers for America's veterans; all residual funds to benefit nonprofit, Folds of Honor DALLAS , Oct. 9, 2025 /PRNewswire/ -- SSCP, an Appl
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
08:00am, Wednesday, 08'th Oct 2025
SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics
BrandPilot AI to Present AI-Powered Ad Waste Solutions at BrightonSEO & HERO Conf San Diego
12:46pm, Monday, 22'nd Sep 2025
Company Highlights Industry-Leading Approach to Search and Paid Media Optimization Toronto, Ontario--(Newsfile Corp. - September 22, 2025) - BrandPilot AI Inc. (CSE: BPAI) (OTCQB: BPAIF) ("BrandPilot"
Disruptive Theme of the Week: Top YTD Themes in the Rearview Mirror
01:23pm, Wednesday, 10'th Sep 2025
It may not be the end of the quarter yet, but we have made it through summer, and that seems like a good checkpoint to evaluate the top ETF investment themes YTD. Let's take a moment to look in this y
HERO: Falling Short Of Its Core Objectives
12:29am, Saturday, 06'th Sep 2025
HERO is a hold due to its inability to capture high-growth, innovative, and paradigm-shifting gaming companies, lagging behind peers like ESPO. The ETF's top holdings—Electronic Arts, Nintendo, and
Why HERO, TTWO, AND RBLX are Must-Buy Stocks Today
11:06am, Tuesday, 26'th Aug 2025
The company recently posted 21% year-over-year revenue growth to $1.1 billion.
